Atopic Dermatitis Eczema Clinical Trial
Official title:
Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study
Metal allergen patch test study.
A single application of an investigational patch test panel containing 11 hydrogel metal allergens and a corresponding patch test panel containing 11 petrolatum metal allergens will be applied to the upper back of human subjects to test diagnostic efficacy and safety. Patch test panels will be removed after being worn for approximately 48 hours. Study will require 6 visits over the course of 21 days; patch application, patch removal and 4 patch test site evaluation visits at days 4, 7, 14 and 21. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05579899 -
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
|
Phase 2 | |
| Terminated |
NCT04085549 -
Effects of a Berry Oil Cream on Atopic Eczema and Skin
|
N/A | |
| Recruiting |
NCT05578482 -
Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis
|
Phase 4 | |
| Completed |
NCT03540043 -
Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT03293030 -
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
|
Phase 4 | |
| Completed |
NCT03386032 -
8-Week Atopic Dermatitis (AD) Treatment Study
|
Phase 3 | |
| Completed |
NCT03667014 -
The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients
|
Phase 4 | |
| Terminated |
NCT05382819 -
A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis
|
Phase 1 | |
| Completed |
NCT04537468 -
Development of a Method to Measure mRNA Levels in Skin Samples
|
N/A | |
| Completed |
NCT03268174 -
Cosmetic Study to Improve the Appearance of Skin Afflicted With Mild to Moderate Atopic Dermatitis.
|
N/A | |
| Active, not recruiting |
NCT03859986 -
Study in Subjects With Moderate Atopic Dermatitis
|
Phase 2 | |
| Completed |
NCT04800185 -
Characterizing Skin Microbiome Change in Atopic Dermatitis
|
Early Phase 1 | |
| Completed |
NCT06361992 -
Efficacy and Safety of Blue Cap for the Treatment of Atopic Dermatitis in Children
|
Phase 3 | |
| Recruiting |
NCT06024499 -
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
|
Phase 2 | |
| Recruiting |
NCT03742414 -
Seal, Stopping Eczema and Allergy Study
|
Phase 2 | |
| Not yet recruiting |
NCT06454942 -
Impact of Regular Consumption of Eggs and Nutrients Fortified Eggs on Eczema Condition in Singapore Individuals
|
N/A | |
| Completed |
NCT03090178 -
Sleep & Quality of Life Evaluation of Patients With Atopic Dermatitis Based on E-diary on a Smartphone Application and Actigraphy
|
N/A | |
| Recruiting |
NCT05935085 -
This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects With Moderate to Severe Atopic Dermatitis (AD).
|
Phase 2 | |
| Recruiting |
NCT03795506 -
TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)
|
N/A | |
| Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|